Advertisement

Topics

Microbiotica Company Profile

09:56 EDT 18th June 2018 | BioPortfolio

Microbiotica was established in 2016 to develop and commercialise ground-breaking research into the role of the human microbiome in health and disease and its application to medicine conducted in the Host-Microbiotica Interactions Laboratory (“HMIL”) at the Sanger Institute. The Company was founded by Dr Mike Romanos, Dr Trevor Lawley and Professor Gordon Dougan, FRS. Microbiotica is based at the Wellcome Genome Campus in Cambridge, UK, with offices in the Biodata Innovation Centre and laboratories in the Sanger Institute. It has a strategic collaboration with Genentech, a member of the Roche Group, in the field of inflammatory bowel disease (IBD).


News Articles [17 Associated News Articles listed on BioPortfolio]

Genentech and Microbiotica to develop new IBD medicines

Genentech has formed a multi-year strategic alliance with Wellcome Sanger Institute’s Microbiotica to address inflammatory bowel disease (IBD). Focused on...Read More... The post Genentech and M...

Microbiotica, Genentech enter into $534m IBD collaboration

Microbiotica has partnered with Genentech to discover, develop and commercialize biomarkers, targets and medicines for inflammatory bowel disease (IBD).

Genentech signs microbiome deal around IBD with Microbiotica

Roche’s Genentech Inc. received options to license from Microbiotica Ltd. biomarkers, targets, and drug candidates in the microbiome area for inflammatory bowel disease (IBD).

Genentech, Microbiotica to collaborate on R&D for microbiome-based IBD

Roche Group member Genentech and Microbiotica signed a multiyear partnership to create and market microbiome-based biomarkers -More- 

Genentech and Microbiotica Ink Multi-Year Collaboration Deal

Genentech, a Roche company, and Microbiotica signed a multi-year strategic collaboration to discover, develop and commercialize biomarkers, targets and drugs for inflammatory bowel disease (IBD).

Microbiotica collaborates with Genentech to develop drugs for IBD

Microbiotica, a leading player in microbiome-based therapeutics spun out of the Wellcome Sanger Institute, today announced that it has entered into a multi-year strategic collaboration with Genentech,...

Microbiotica to Present at Top Microbiome Conferences

Cambridge, UK, 22 May 2018 – Microbiotica, a leading player in microbiome-based therapeutics, announces that it will present at leading microbiome conferences throughout May and June. Mic...

Microbiotica & Genentech enter collaboration for investigational inflammatory bowel disease medicines

Cambridge Innovation Capital portfolio company, Microbiotica, has entered into a multi-year strategic collaboration to discover, develop and commercialise biomarkers, targets and medicines for inflamm...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Microbiotica

Microbiotica was established in 2016 to develop and commercialise ground-breaking research into the role of the human microbiome in health and disease and its application to medic...

More Information about "Microbiotica" on BioPortfolio

We have published hundreds of Microbiotica news stories on BioPortfolio along with dozens of Microbiotica Clinical Trials and PubMed Articles about Microbiotica for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Microbiotica Companies in our database. You can also find out about relevant Microbiotica Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record